FDA Clears Zyn Nicotine Pouches for Lower-Risk Label
TL;DR Summary
The FDA cleared 20 Philip Morris–owned Zyn nicotine pouches to carry a modified-risk claim, saying switching from cigarettes lowers the risk of several diseases; this gives the company a major marketing advantage as cigarette sales decline, though the FDA stresses no tobacco product is safe; the products come in 3 mg and 6 mg strengths across multiple flavors.
- FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes CNBC
- Exclusive: FDA allows ZYN to sell pouches on health benefits Axios
- Some ZYN nicotine pouches can be sold as safer than cigarettes, FDA says NBC News
- FDA allows Zyn pouches to be marketed as less harmful than cigarettes The Hill
- Philip Morris Says It Can Market Zyn as Safer Than Cigarettes Bloomberg.com
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
3 min
vs 3 min read
Condensed
90%
584 → 58 words
Want the full story? Read the original article
Read on CNBC